Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 1/20 | 0.43 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.43 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.43 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.37 |
| ▸ | ELANE | P08246 | 1/20 | 0.37 |
| ▸ | CTSK | P43235 | 1/20 | 0.37 |
| ▸ | NR1H2 | P55055 | 2/20 | 0.36 |
| ▸ | BUB1 | O43683 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | DDB1 | Q16531 | 2/20 | 0.36 |
| ▸ | CRBN | Q96SW2 | 2/20 | 0.36 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19586194 | 0.92 | BCHE (0.41) | BCHECHRM2CHRM1CHRM3USP2 | |
| SCHEMBL14078162 | 0.87 | BCHE (0.38) | BCHECHRM2CHRM1CHRM3USP2 | |
| SCHEMBL3670943 | 0.79 | ALDH1A1 (0.36) | CHRM2CHRM1CHRM3 | |
| SCHEMBL6949587 | 0.79 | MEN1 (0.56) | BCHEKDM4E | |
| SCHEMBL29466630 | 0.79 | MEN1 (0.56) | BCHEKDM4E | |
| SCHEMBL9480226 | 0.79 | BUB1 (0.36) | BCHECHRM2CHRM1CHRM3USP2 | |
| SCHEMBL19586495 | 0.77 | CHRM2 (0.41) | BCHECHRM2CHRM1CHRM3ELANE | |
| SCHEMBL19586637 | 0.77 | ELANE (0.47) | BCHECHRM2CHRM1CHRM3ELANE | |
| SCHEMBL16205507 | 0.76 | KDM4E (0.39) | BCHECHRM2CHRM1CHRM3USP2 | |
| SCHEMBL31218507 | 0.76 | CHRM2 (0.44) | BCHECHRM2CHRM1CHRM3USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119930872-A | Catalyst system, prepolymerized catalyst composition and olefin polymerization process | 中国石油化工股份有限公司 | 2025-05-06 | — | — | CN | claimed |
| CN-119930872-A | Catalyst system, prepolymerized catalyst composition and olefin polymerization process | 中国石油化工股份有限公司 | 2025-05-06 | — | — | CN | disclosed |
| US-20240246967-A1 | AXL COMPOUNDS | ARCUS BIOSCIENCES, INC. | 2024-07-25 | — | — | US | disclosed |
| US-20240226115-A1 | AXL INHIBITOR COMPOUNDS | ARCUS BIOSCIENCES, INC. | 2024-07-11 | — | — | US | disclosed |
| EP-4341261-A1 | AXL COMPOUNDS | Arcus Biosciences, Inc. (US) | 2024-03-27 | — | — | EP | disclosed |
| CN-117337288-A | AXL inhibitor compounds | 艾库斯生物科学有限公司 | 2024-01-02 | — | — | CN | disclosed |
| US-11723897-B2 | Fatty acids as anti-inflammatory agents | University of Pittsburgh—of the Commonwealth System of Higher Education (US) | 2023-08-15 | — | — | US | disclosed |
| WO-2022246177-A1 | AXL COMPOUNDS | ARCUS BIOSCIENCES, INC. (US) | 2022-11-24 | — | — | WO | disclosed |
| US-10177410-B2 | Lithium secondary battery electrolyte and lithium secondary battery including same | SK INNOVATION CO., LTD. (KR) | 2019-01-08 | — | — | US | disclosed |
| US-20160322665-A1 | Lithium Secondary Battery Electrolyte and Lithium Secondary Battery Including Same | SK INNOVATION CO., LTD. (KR) | 2016-11-03 | — | — | US | disclosed |
| US-20100280259-A1 | N-Tert-Butoxycarbonyl-2-Pyrrolidinones and Production Method Thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-11-04 | — | — | US | disclosed |
| US-20090163722-A1 | N-TERT-BUTOXYCARBONYL-2-PYRROLIDINONES AND PRODUCTION METHOD THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-06-25 | — | — | US | disclosed |
| CN-101415676-A | N-tert-butoxycarbonyl-2-pyrrolidinone compounds and method for producing the same | SUMITOMO CHEMICAL CO (JP) | 2009-04-22 | — | — | CN | disclosed |
| US-20090023859-A1 | POLYOXYALKYLENE DERIVATIVE | NOF CORPORATION (JP) | 2009-01-22 | — | — | US | disclosed |
| EP-2008999-A1 | N-TERT-BUTOXYCARBONYL-2-PYRROLIDINONES AND PROCESS FOR PRODUCING THE SAME | Sumitomo Chemical Company, Limited (JP) | 2008-12-31 | — | — | EP | disclosed |
| EP-0530469-B1 | Process for the preparation of organic compounds carrying tert.-butoxycarbonyl groups | HOECHST AG (DE) | 1995-11-29 | — | — | EP | disclosed |
| US-5397846-A | Process for preparing organic compounds carrying tert-butyloxycarbonyl groups | HOECHST AKTIENGESELLSCHAFT (DE) | 1995-03-14 | — | — | US | disclosed |
| EP-0530469-A1 | Process for the preparation of organic compounds carrying tert.-butoxycarbonyl groups | HOECHST AKTIENGESELLSCHAFT (DE) | 1993-03-10 | — | — | EP | disclosed |
| US-5030715-A | Antibacterial agents; immunomodulators; auto immune diseases | ROUSSEL UCLAF (FR) | 1991-07-09 | — | — | US | disclosed |
| US-4169941-A | ANTIBIOTICS, URETHANE-TYPE AMINO PROTECTION REACTION | ABBOTT LABORATORIES (US) | 1979-10-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240226115-A1 | AXL INHIBITOR COMPOUNDS | AXL, BTK, MERTK | BCHE 4681/4885CHRM2 4396/4885CHRM1 4297/4885 |
| US-20090163722-A1 | N-TERT-BUTOXYCARBONYL-2-PYRROLIDINONES AND PRODUCTION METHOD THEREOF | TERT, CBR1, TELO2 | BCHE 514/4885CHRM2 1573/4885CHRM1 622/4885 |
| US-20240246967-A1 | AXL COMPOUNDS | AXL, FLT3, BTK | BCHE 4613/4885CHRM2 3883/4885CHRM1 3851/4885 |
| US-20100280259-A1 | N-Tert-Butoxycarbonyl-2-Pyrrolidinones and Production Method Thereof | TERT, CBR1, TELO2 | BCHE 514/4885CHRM2 1573/4885CHRM1 622/4885 |
| US-11723897-B2 | Fatty acids as anti-inflammatory agents | ALOX15B, FFAR1, ALOX12 | BCHE 1398/4885CHRM2 2845/4885CHRM1 2792/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.